Yes, Neupogen Boosts White Blood Cells
Neupogen (filgrastim) is a synthetic version of granulocyte colony-stimulating factor (G-CSF), a natural protein that stimulates the bone marrow to produce neutrophils, a type of white blood cell critical for fighting infections.[1] Doctors prescribe it primarily to treat neutropenia, a low white blood cell count often caused by chemotherapy, which increases infection risk.
How Does It Work Exactly?
It binds to receptors on precursor cells in the bone marrow, speeding up neutrophil production and release into the bloodstream. This raises absolute neutrophil counts (ANC) within days, typically peaking at 24-48 hours after injection.[1][2] It's given as a subcutaneous injection, usually daily until ANC recovers.
When Is It Used Most?
- Chemotherapy-induced neutropenia: Prevents or shortens low white cell periods post-chemo.
- Bone marrow transplants: Supports white cell recovery after stem cell procedures.
- Severe chronic neutropenia: Maintains counts in congenital or idiopathic cases.
- Off-label or acute settings: Sometimes for infections or mobilization of stem cells for donation.[1]
Not approved for red blood cells or platelets—those have separate drugs like Epogen or Promacta.
What About Side Effects on White Cells?
Commonly causes bone pain (from rapid marrow expansion), but it doesn't overstimulate other white cells like lymphocytes much. Rare risks include spleen rupture or acute respiratory distress from very high counts (leukocytosis).[2] Monitor ANC to avoid excess.
How Does It Compare to Neulasta?
Neulasta (pegfilgrastim) is a longer-acting version of filgrastim, needing just one dose per chemo cycle versus daily Neupogen shots. Both target neutrophils specifically; Neulasta lasts 2 weeks.[1]
Biosimilars and Availability
Zarxio (filgrastim-sndz) is the first FDA-approved Neupogen biosimilar, entering in 2015 at lower cost. Others like Nivestym followed. Patents on original Neupogen expired around 2015 in the US; check DrugPatentWatch.com for exact expiry details and generics.[3]
[1] Neupogen Prescribing Information, Amgen.
[2] FDA Label for Filgrastim.
[3] DrugPatentWatch.com - Neupogen Patents.